CD154 regulates primate humoral immunity to influenza

American Journal of Transplantation

Volumn 3, Issue 6, 2003, Pages 680-688

  Crowe Jr , James E ^a,b   Sannella, Edith C ^a   Pfeiffer, Steffen ^a   Zorn III, George L ^a   Azimzadeh, Agnes ^a   Newman, Roland ^c   Miller, Geraldine G ^a   Pierson III, Richard N ^a,d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BIOGEN   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antibodies; Costimulation; Tolerance; Transplantation; Vaccination

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; MONOCLONAL ANTIBODY IDEC 131;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; MACACA; MALE; NONHUMAN; ORGAN TRANSPLANTATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; CD40 LIGAND; FEMALE; MACACA FASCICULARIS; MALE; ORTHOMYXOVIRIDAE INFECTIONS; VACCINES;

EID: 0038545706     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00106.x     Document Type: Article

References (25)

1. Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 1996; 93: 13967-13972.
2. Larsen CP, Alexander DZ, Hollenbaugh D et al. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 1996; 61: 4-9.
3. Larsen CP, Elwood ET, Alexander DZ et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434-438.
4. Kirk AD, Harlan DM, Armstrong NN et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 1997; 94: 878-894.
5. Kirk AD, Burkly LC, Batty DS et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999; 5: 686-693.
6. Kenyon NS, Chatzipetrou M, Masetti M et al. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci USA 1999; 96: 8132-8317.
7. Kenyon NS, Fernandez LA, Lehmann R et al. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes 1999; 48: 1473-1781.
8. Pierson RN, Chang AC, Blum MG et al. Prolongation of primate cardiac allograft survival by treatment with anti-CD40 ligand (CD154) antibody. Transplantation 1999; 68: 1800-1805.
9. Allen RC, Armitage RJ, Conley ME et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993; 259: 990-993.
10. Aruffo A, Farrington M, Hollenbaugh D et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993; 72: 291-300.
11. Brams P, Black A, Padlan E et al. A humanized anti-human CD154 monoclonal antibody blocks CD154-CD40 mediated human B cell activation. Int Immunopharmacol 2001; 1: 277-294.
12. Snyder M, Banks S, Murphy BR. Determination of antibody response to influenza virus surface glycoproteins by kinetic enzyme-linked immunosorbent assay. J Clin Microbiol 1988; 26: 2034-2040.
13. Wasowska B, Baldwin, WM, 3rd, Howell DN, Sanfilippo F. The association of enhancement of renal allograft survival by donor- specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses. Transplantation 1993; 56: 672-680.
14. Whimbey E, Elting LS, Couch RB et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant 1994; 13: 437-440.
15. Ljungman P. Respiratory virus infections in bone marrow transplant recipients: the European perspective. Am J Med 1997; 102 (3A): 44-47.
16. Kimball P, Verbeke S, Flattery M, Rhodes C, Tolman D. Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients. Transplantation 2000; 69: 2449-2451.
17. Dengler TJ, Strnad N, Buhring I et al. Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 1998; 66: 1340-1347.
18. Admon D, Engelhard D, Strauss N, Goldman N, Zakay-Rones Z. Antibody response to influenza immunization in patients after heart transplantation. Vaccine 1997; 15: 1518-1522.
19. Rimmelzwaan GF, Baars M, van Beek R et al. Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and ISCOM vaccines. J Gen Virol 1997; 78: 757-765.
20. Hurwitz ES, Haber M, Chang A et al. Studies of the 1996-97 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness. J Infect Dis 2000; 182: 1218-1221.
21. Castigli E, Alt FW, Davidson L et al. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc Natl Acad Sci USA 1994; 91: 12135-12139.
22. Kawabe T, Naka T, Yoshida K et al. The immune responses in CD40-deficient mice. impaired immunoglobulin class switching and germinal center formation. Immunity 1994; 1: 167-178.
23. Foy TM, Shepherd DM, Durie FH, Aruffo A, Ledbetter JA, Noelle RJ. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J Exp Med 1993; 178: 1567-1575.
24. Xu J, Foy TM, Laman JD et al. Mice deficient for the CD40 ligand. Immunity 1994; 1: 423-431.
25. Borrow P, Tishon A, Lee S et al. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J Exp Med 1996; 183: 2129-2142.